{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:55:24Z","timestamp":1792670124037,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/jnci\/dju427","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T08:43:41Z","timestamp":1424940221000},"source":"Crossref","is-referenced-by-count":351,"title":["Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer"],"prefix":"10.1093","volume":"107","author":[{"given":"Fotios","family":"Loupakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cremolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K. H.","family":"Maus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Antoniotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan J.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert I.","family":"Hurwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Saltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,20]]},"reference":[{"issue":"25","key":"key\n\t\t\t\t20170520230331_CIT0001","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1056\/NEJMra0804588","article-title":"Molecular origins of cancer: molecular basis of colorectal cancer","volume":"361","author":"Markowitz","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20170520230331_CIT0002","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrclinonc.2011.15","article-title":"Implementing prognostic and predictive biomarkers in CRC clinical trials","volume":"8","author":"Van Schaeybroeck","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520230331_CIT0003","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11912-011-0162-3","article-title":"Predictive and prognostic markers in colorectal cancer","volume":"13","author":"George","year":"2011","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"key\n\t\t\t\t20170520230331_CIT0004","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","article-title":"DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy","volume":"103","author":"Sinicrope","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20170520230331_CIT0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bjc.6605164","article-title":"Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer","volume":"101","author":"Souglakos","year":"2009","journal-title":"Br J Cancer"},{"issue":"20","key":"key\n\t\t\t\t20170520230331_CIT0006","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"issue":"10","key":"key\n\t\t\t\t20170520230331_CIT0007","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"issue":"4\u20135","key":"key\n\t\t\t\t20170520230331_CIT0008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000171605","article-title":"Are right- and left-sided colon neoplasms distinct tumors?","volume":"15","author":"Distler","year":"1997","journal-title":"Dig Dis"},{"issue":"5","key":"key\n\t\t\t\t20170520230331_CIT0009","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"issue":"10","key":"key\n\t\t\t\t20170520230331_CIT0010","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20170520230331_CIT0011","first-page":"755","article-title":"Distinguishing right from left colon by the pattern of gene expression","volume":"12","author":"Glebov","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"key\n\t\t\t\t20170520230331_CIT0012","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gut.2003.036848","article-title":"Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid","volume":"54","author":"Birkenkamp-Demtroder","year":"2005","journal-title":"Gut"},{"issue":"10","key":"key\n\t\t\t\t20170520230331_CIT0013","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20170520230331_CIT0014","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrg3317","article-title":"Evolution of the cancer genome","volume":"13","author":"Yates","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"9","key":"key\n\t\t\t\t20170520230331_CIT0015","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1245\/s10434-008-0015-y","article-title":"Is there a difference in survival between right- versus left-sided colon cancers?","volume":"15","author":"Meguid","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520230331_CIT0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Colon\/Rectum Carcinomas (Primary Tumor) Study Group. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis Colon Rectum"},{"issue":"33","key":"key\n\t\t\t\t20170520230331_CIT0017","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2011.36.4414","article-title":"Mortality by stage for right- versus left-sided colon cancer: analysis of surveillance, epidemiology, and end results\u2014Medicare data","volume":"29","author":"Weiss","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520230331_CIT0018","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jclinpath-2011-200340","article-title":"Mucinous subtype as prognostic factor in colorectal cancer: a systematic review and meta-analysis","volume":"65","author":"Verhulst","year":"2012","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20170520230331_CIT0019","article-title":"Clinicaltrials.gov: Evaluation of VEGF polymorphism as predictive factor in metastatic colorectal cancer treated with Folfiri plus bevacizumab (PROVETTA)"},{"key":"key\n\t\t\t\t20170520230331_CIT0020","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.3518","article-title":"Prospective evaluation of candidate SNPs of VEGF\/VEGFR pathway in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI plus bevacizumab (BV)","volume":"30","author":"Cremolini","year":"2012","journal-title":"J Clin Oncol"},{"issue":"23","key":"key\n\t\t\t\t20170520230331_CIT0021","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"issue":"12","key":"key\n\t\t\t\t20170520230331_CIT0022","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","article-title":"Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study","volume":"26","author":"Saltz","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520230331_CIT0023","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/bjc.2011.201","article-title":"XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results","volume":"105","author":"Cassidy","year":"2011","journal-title":"Br J Cancer"},{"issue":"2","key":"key\n\t\t\t\t20170520230331_CIT0024","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdf034","article-title":"Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients","volume":"13","author":"K\u00f6hne","year":"2002","journal-title":"Ann Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170520230331_CIT0025","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/annonc\/mdt253","article-title":"Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer","volume":"24","author":"Boisen","year":"2013","journal-title":"Ann Oncol"},{"issue":"3","key":"key\n\t\t\t\t20170520230331_CIT0026","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.clcc.2011.03.024","article-title":"A review of excision repair cross-complementation group 1 in colorectal cancer","volume":"10","author":"Bohanes","year":"2011","journal-title":"Clin Colorectal Cancer"},{"key":"key\n\t\t\t\t20170520230331_CIT0027","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.3640","article-title":"mRNA expression levels of candidate genes and clinical outcome in mCRC patients treated with FOLFOXIRI plus bevacizumab (bev) or FOLFIRI plus bev in the TRIBE study","volume":"32","author":"Yang","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20170520230331_CIT0028","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/tpj.2011.29","article-title":"TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trials","volume":"12","author":"Grimminger","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"key\n\t\t\t\t20170520230331_CIT0029","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.3527","article-title":"Gene expression profiles and tumor locations in colorectal cancer (left vs. right vs. rectum)","volume":"31","author":"Maus","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170520230331_CIT0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1200\/JCO.2011.39.5814","article-title":"Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer","volume":"30","author":"Popovici","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7407","key":"key\n\t\t\t\t20170520230331_CIT0031","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature11252","article-title":"Comprehensive molecular characterization of human colon and rectal cancer","volume":"487","author":"Cancer Genome Atlas Network","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170520230331_CIT0032","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.30_suppl.32","article-title":"Epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab therapy in combination with oxaliplatin (Ox) and 5FU in first-line treatment of advanced colorectal cancer (aCRC)","volume":"30","author":"Adams","year":"2012","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170520230331_CIT0033","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.3528","article-title":"Location of colon cancer (right-sided [RC] versus left-sided [LC]) as a predictor of benefit from cetuximab (CET): NCIC CTG CO.17","volume":"31","author":"Brule","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170520230331_CIT0034","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.3526","article-title":"Proximal and distal colon tumors as distinct biologic entities with different prognoses","volume":"31","author":"Missiaglia","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20170520230331_CIT0035","volume-title":"Larsen\u2019s human embryology","author":"Schoenwolf","year":"2009","edition":"Fourth"},{"issue":"6","key":"key\n\t\t\t\t20170520230331_CIT0036","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/107\/3\/dju427\/17314111\/dju427.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T05:38:17Z","timestamp":1598765897000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,20]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,2,20]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju427","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725368072.793550897","asserted-by":"object"}]},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,20]]}}}